Kintor Pharmaceutical Limited Profit Margin

The latest profit margin for KNTPF is -344.47% as of June 2026. That compares with -3165.71% in the prior-year period — up 89.1% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Kintor Pharmaceutical Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, KNTPF's profit margin moved from -3165.71% to -344.47% — a 89.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Kintor Pharmaceutical Limited's valuation or profitability profile.

Against Healthcare companies, KNTPF currently prints -344.47% for profit margin, while the sector average sits near 9.48%. That is roughly 3733.2% below the sector mean. Large gaps often invite a closer look at Kintor Pharmaceutical Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Kintor Pharmaceutical Limited converts resources into returns. At -344.47%, KNTPF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3165.71% in the prior-year period — up 89.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting KNTPF's profit margin (-344.47%), review year-over-year change from -3165.71%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.